
LEI: 635400TLVVBNXLFHWC59
Regulatory Announcement
TRANSACTION IN OWN SHARES
|
||||||
|
Euronext Dublin |
|
||||
Number of Ordinary Shares purchased: |
23,599 |
|
||||
Highest price paid per Ordinary Share: |
€94.1500 |
|
||||
Lowest price paid per Ordinary Share: |
€92.9000 |
|
||||
Volume weighted average price paid per Ordinary Share: |
€93.2817 |
|
||||
|
|
|
||||
The Ordinary Shares purchased form part of Kerry's intention to buyback Ordinary Shares of a total value of up to |
||||||
Following settlement of the above transactions and subsequent share cancellation Kerry will have 163,899,893 Ordinary Shares in issue (excluding treasury shares). |
||||||
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the "Market Abuse Regulation") (including as it forms part of retained EU law in the
|
||||||
|
CONTACT INFORMATION |
|
|
|||
|
|
|
|
|
||
Group Secretary |
|
|
||||
|
|
|
|
|
||
|
+353 66 7182000 | TraleeCoSec@kerry.ie |
|
|
|
||
|
|
|
|
|
||
Website |
|
|
||||
|
|
|
|
|||
|
|
|
|
|||
|
Issuer name: |
|
|
|
|
LEI |
|
635400TLVVBNXLFHWC59 |
|
|
ISIN: |
|
IE0004906560 |
|
|
Intermediary name: |
|
|
||
Intermediary code: |
DAVYIE21 |
|
|
|
Time zone: |
|
GMT |
|
|
Currency: |
|
EUR |
|
|
|
|
|
|
|
Aggregated Information |
||||
|
|
|
|
|
Trading venue |
Currency |
Volume Weighted Average Price |
Aggregated volume |
|
Euronext Dublin |
EUR |
€93.2817 |
23,599 |
|
|
|
|
|
|
Euronext Dublin |
||||
|
|
|
|
|
Number of |
Price per Share (EUR) |
Trading Venue |
Time of Transaction |
MatchID |
4025 |
94.1500 |
Euronext Dublin |
08:51:15 |
00044785007TRLO0-1 |
1055 |
93.3500 |
Euronext Dublin |
11:23:42 |
00044785465TRLO0-1 |
2684 |
93.5000 |
Euronext Dublin |
11:50:30 |
00044785570TRLO0-1 |
7562 |
93.1500 |
Euronext Dublin |
15:05:31 |
00044786526TRLO0-1 |
8273 |
92.9000 |
Euronext Dublin |
15:27:29 |
00044786778TRLO0-1 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the